Kang Zhang

Affiliations: 
University of California, San Diego, La Jolla, CA 
Area:
Retinal genetics
Google:
"Kang Zhang"
Mean distance: 16.15 (cluster 31)
 
SNBCP
BETA: Related publications

Publications

You can help our author matching system! If you notice any publications incorrectly attributed to this author, please sign in and mark matches as correct or incorrect.

Chen D, Chao DL, Rocha L, et al. (2020) The lipid elongation enzyme ELOVL2 is a molecular regulator of aging in the retina. Aging Cell. e13100
Laurent JM, Fu X, German S, et al. (2019) Big DNA as a tool to dissect an age-related macular degeneration-associated haplotype. Precision Clinical Medicine. 2: 1-7
Yuan P, Liang ZK, Liang H, et al. (2019) Expanding the phenotypic and genetic spectrum of Chinese patients with congenital absence of vas deferens bearing CFTR and ADGRG2 alleles. Andrology
Wang P, Li X, Zhu W, et al. (2018) 3D bioprinting of hydrogels for retina cell culturing. Bioprinting (Amsterdam, Netherlands). 11
Stern JH, Tian Y, Funderburgh J, et al. (2018) Regenerating Eye Tissues to Preserve and Restore Vision. Cell Stem Cell. 22: 834-849
Moreno AM, Fu X, Zhu J, et al. (2018) In Situ Gene Therapy via AAV-CRISPR-Cas9-Mediated Targeted Gene Regulation. Molecular Therapy : the Journal of the American Society of Gene Therapy
Lu Y, Zhang K. (2018) Cellular Reprogramming in the Retina - Seeing the Light. The New England Journal of Medicine. 378: 1059-1060
Fu X, Huu VAN, Duan Y, et al. (2018) Clinical applications of retinal gene therapies Precision Clinical Medicine. 1: 5-20
Zhu J, Ming C, Fu X, et al. (2017) Gene and mutation independent therapy via CRISPR-Cas9 mediated cellular reprogramming in rod photoreceptors. Cell Research
Wang W, Gawlik K, Lopez J, et al. (2016) Genetic and environmental factors strongly influence risk, severity and progression of age-related macular degeneration. Signal Transduction and Targeted Therapy. 1: 16016
See more...